my country's plant extracts call for national standards

Chinese patent medicine is frustrated by EU, while plant extract has a bright future Recently, the first International Symposium on the standardization of extracts of traditional Chinese medicine and plant medicine was held in Wuhan The participants called for the establishment of a unified international standard for Chinese plant extracts as soon as possible to meet the needs of the international market The seminar was sponsored by the professional committee of Chinese traditional medicine quality standards, organized by Wuhan Optical Valley Biological City, and attended by scientific research institutes and industry chambers of Commerce from the industry of traditional Chinese medicine and plant extract It is reported that plant extracts, as the main raw materials of modern plant medicine preparations, integrate modern pharmaceutical technology and become the core product in the market of natural medicine and health care products The huge market space of natural medicine and health care products makes plant extracts become the hot product in the international market When Chinese traditional medicine is difficult to open the market door of developed countries due to the "identity" problem, plant extract becomes fashionable because of its "return to nature" and "green consumption", which is highly respected in western developed countries, opening up a new path for the internationalization of traditional Chinese medicine China's plant extract industry has unique development advantages due to the guidance of traditional Chinese medicine theory At present, China's plant extract industry has formed a certain scale, and the mainstream enterprises in terms of production equipment and technical capacity can fully compete with the world's major extraction producing countries, such as Germany, Italy, Spain, etc According to statistics, plant extracts are the main force in the export of traditional Chinese medicine Last year, the export volume of this field rose to US $801.5 billion, accounting for 41.92% of the total export volume of traditional Chinese medicine After the 7-year transition period of EU's "traditional botanical medicine registration procedure directive" ended on April 30 this year, due to the unsuccessful registration of Chinese patent medicine in China, Chinese patent medicine will leave the EU temporarily Industry insiders believe that the EU market as a large market for botanical drugs, the frustration of Chinese patent medicine or will create an opportunity for plant extracts At present, there are hundreds of plant extracts produced in China, among which Ginkgo biloba extract, green tea extract and ginseng extract have been produced and exported on a large scale These products have a large market share in western countries Although China's plant extract industry has made great progress in recent years, and the industrial concentration has increased significantly, there are still some deficiencies in the industry, such as small scale, low product innovation ability, weak international market development ability, etc As a new industry, most plant extracts in China are lack of uniform standards Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of health care products, said that China's production enterprises have always followed the customer standard, that is, to produce according to the requirements of customers Although the operation is simple, the disadvantages are obvious: once the customer raises an objection to the product quality, the production enterprise will be controlled by others, many enterprises have suffered losses and suffered losses At the seminar, a number of experts called on China to establish a unified international standard as soon as possible At the same time, advanced inspection and detection technologies and methods should be adopted according to international standards to establish a complete and standardized industry standard system for more plant extract varieties.